These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
207 related items for PubMed ID: 1285022
1. Fibrin-specific fibrinolysis. Collen D, Lijnen HR. Ann N Y Acad Sci; 1992 Dec 04; 667():259-71. PubMed ID: 1285022 [No Abstract] [Full Text] [Related]
2. Progress of fibrinolysis during tumor necrosis factor infusions in humans. Concomitant increase in tissue-type plasminogen activator, plasminogen activator inhibitor type-1, and fibrin(ogen) degradation products. van Hinsbergh VW, Bauer KA, Kooistra T, Kluft C, Dooijewaard G, Sherman ML, Nieuwenhuizen W. Blood; 1990 Dec 01; 76(11):2284-9. PubMed ID: 1701665 [Abstract] [Full Text] [Related]
7. Fibrinolysis is down-regulated in mouse collagen-induced arthritis, but its normalization does not alleviate the course of disease. Kwieciński J, Josefsson E, Jin T. Inflamm Res; 2011 Nov 01; 60(11):1021-9. PubMed ID: 21786185 [Abstract] [Full Text] [Related]
9. Thrombolytic therapy in the eighties. Verstraete M, Collen D. Blood; 1986 Jun 10; 67(6):1529-41. PubMed ID: 2423156 [No Abstract] [Full Text] [Related]
10. The intrinsic lysis concept. Gurewich V, Liu JN, Pannell R. Ann N Y Acad Sci; 1992 Dec 04; 667():224-32. PubMed ID: 1309040 [No Abstract] [Full Text] [Related]
11. Plasminogen activator in acute myeloid leukaemic marrows: u-PA in contrast to t-PA in normal marrow. McWilliam N, Robbie L, Booth N, Bennett B. Br J Haematol; 1998 Jun 04; 101(4):626-31. PubMed ID: 9674732 [Abstract] [Full Text] [Related]
13. The interaction of streptokinase.plasminogen activator complex, tissue-type plasminogen activator, urokinase and their acylated derivatives with fibrin and cyanogen bromide digest of fibrinogen. Relationship to fibrinolytic potency in vitro. Cassels R, Fears R, Smith RA. Biochem J; 1987 Oct 15; 247(2):395-400. PubMed ID: 3122725 [Abstract] [Full Text] [Related]
14. Tissue plasminogen activator (tPA) inhibits plasmin degradation of fibrin. A mechanism that slows tPA-mediated fibrinolysis but does not require alpha 2-antiplasmin or leakage of intrinsic plasminogen. Wu JH, Diamond SL. J Clin Invest; 1995 Jun 15; 95(6):2483-90. PubMed ID: 7769094 [Abstract] [Full Text] [Related]
15. [PC-12 cells hydrolyze the fibrin clot by producing both plasminogen and its tissue activator]. Petrova IuI, Savchuk OM, Kalashnyk OM, Platonova TM, Skok MV, Cederholm-Williams S. Ukr Biokhim Zh (1999); 2004 Jun 15; 76(2):64-8. PubMed ID: 15915713 [Abstract] [Full Text] [Related]